Back to the main directory
EarningsReview / Equity
- Espresso | Alcon | Reduce | Good prospects, optimistic valuation by Kepler Cheuvreux
- Fabege (Hold, TP: SEK130.00) - Dents in the perfect track record by DnB Markets
- Atrium Ljungberg (Buy, TP: SEK184.00) - Retail discount to remain by DnB Markets
- All rise by BNP Paribas
- Basel 4 compliance provides flexibility by BNP Paribas
- Scandic Hotels (Buy, TP: SEK125.00) - Seasonally weak Q1e but no drama by DnB Markets
- Fjord1 (Buy, TP: NOK48.00) - Focus on upcoming tenders by DnB Markets
- Promising results and 2019-21e outlook by BNP Paribas
- GasLog (Buy, TP: USD24.00) - Challenging Q1 for spot vessels by DnB Markets
- (8– 12 April 2019) by Oddo BHF
- UMG momentum continues by BNP Paribas
- Espresso | DSM | Buy | Q1: high comps due to vitamin effect by Kepler Cheuvreux
- Espresso | Edenred | Buy | Q1 revenue due on 18 April by Kepler Cheuvreux
- Getinge (Buy, TP: SEK125.00) - Expecting a decent Q1 by DnB Markets
- Strong flows to continue into the following quarters by BNP Paribas
- Novozymes (Sell, TP: DKK230.00) - Awaiting the strategy review by DnB Markets
- Norwegian Finans Holding (Buy, TP: NOK105.00) - Approaching buybacks and dividends by DnB Markets
- Coloplast (Hold, TP: DKK700.00) - Tough comparables in Q2 by DnB Markets
- Avanza Bank (Buy, TP: SEK100.00) - Set for near-term recovery by DnB Markets
- Tele2 (Buy, TP: SEK138.00) - Cost savings could offer upside by DnB Markets
- Yielding Results by BNP Paribas
- Gearing up for the Q1 19 reporting season by BNP Paribas
- Q119 sales and 15 questions for management by BNP Paribas
- Espresso | Peab | Buy | Looking for another solid quarter by Kepler Cheuvreux
- Apple litigation settled by BNP Paribas